MARKET

IONS

IONS

Ionis Pharmaceuticals
NASDAQ
40.65
-0.47
-1.14%
After Hours: 41.00 +0.35 +0.86% 17:39 06/14 EDT
OPEN
41.18
PREV CLOSE
41.12
HIGH
41.31
LOW
40.43
VOLUME
1.39M
TURNOVER
0
52 WEEK HIGH
54.44
52 WEEK LOW
35.95
MARKET CAP
5.93B
P/E (TTM)
-15.2230
1D
5D
1M
3M
1Y
5Y
ALS therapy market seen increasing to nearly $1.3B by 2029
Healthcare ALS therapy market seen increasing to nearly $1.3B by 2029 from $317M in 2019. The market for medicines to treat amyotrophic lateral sclerosis (ALS) in major markets is projected to more than surge. Currently, there are only six treatments for Lou Gehrig's disease.
Seeking Alpha · 17h ago
Ionis Pharmaceuticals Raised to Market Perform From Underperform by Bernstein
Dow Jones · 2d ago
Bernstein Upgrades Ionis Pharmaceuticals to Market Perform
Benzinga · 2d ago
IONIS PHARMACEUTICALS INC <IONS.O>: BERNSTEIN RAISES TARGET PRICE TO $44 FROM $37
Reuters · 2d ago
IONIS PHARMACEUTICALS INC <IONS.O>: BERNSTEIN RAISES TO MARKET PERFORM FROM UNDERPERFORM
Reuters · 2d ago
U.S. RESEARCH ROUNDUP-Adobe, Oracle, Zscaler
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Adobe, Oracle Corp and Zscaler among companies with revised ratings and targets. Adobe raises its target price to $545 from $525; Oracle Corp raises to overweight from underweight.
Reuters · 2d ago
Validea Detailed Fundamental Analysis - IONS
NASDAQ · 5d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (IONS), Replimune Group (REPL) and Roivant Sciences (ROIV)
TipRanks · 6d ago
More
About IONS
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).

Webull offers Ionis Pharmaceuticals Inc stock information, including NASDAQ: IONS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IONS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IONS stock methods without spending real money on the virtual paper trading platform.